IFNA1 and neoplasm: Specifically, while tumor inflammation gene signatures, including TIS, are measuring IFN biology and/or presence of specific T cell populations [2, 6, 20–22], additional signatures (which could be combined with TIS) are needed to gain further insight into additional processes associated with immune escape that could be targeted therapeutically [23].